1 1

Alkriz (Crizotinib)

Alkriz (Crizotinib)

Model Number: Alkriz 250
Brand Name: Alkriz
Origin: Bangladesh
Small Orders: Yes/Available
Tags: ALK inhibitor , ALK-positive NSCLC , Alkriz 250 mg , Anticancer Medicine , Beacon Pharma , Beacon Pharmaceuticals , Cancer Treatment , Crizotinib , Crizotinib 250 mg , Crizotinib capsules , lung cancer medicine , Lung Cancer Treatment , metastatic lung cancer , Non-small Cell Lung Cancer , NSCLC , Oncology Medicine , oral anticancer drug , prescription medicine. , ROS1 Inhibitor , ROS1-positive NSCLC , Targeted Cancer Therapy , TKI , Tyrosine Kinase Inhibitor
View full details
  • Details
  • Description
Packaging Size: 7 × 4 capsules (28 capsules)
Strength: 250 mg
Composition: Crizotinib 250 mg
Treatment: Targeted treatment of ALK-positive or ROS1-positive advanced/metastatic non-small cell lung cancer (NSCLC). Crizotinib inhibits ALK and ROS1 tyrosine kinase signaling.
Form: Capsule
Brand: Alkriz
Quantity Unit: Box/Capsule
Manufacturer: Beacon Pharmaceuticals PLC

  1. Alkriz (Crizotinib) is an oral targeted anticancer medicine manufactured by Beacon Pharmaceuticals PLC. It contains crizotinib, a tyrosine kinase inhibitor (TKI) that blocks abnormal ALK and ROS1 signaling involved in cancer-cell growth. It is primarily used to treat ALK-positive or ROS1-positive metastatic non-small cell lung cancer (NSCLC). Alkriz is available as capsules and should be used under the supervision of an oncologist.

Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.